Stay updated on Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial

Sign up to get notified when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    14 days ago
    Change Detected
    Summary
    The page has been updated to a new revision (v3.2.0) with updated bibliographic details, and a government operating-status notice has been added; an earlier online-ahead-of-print citation has been removed, indicating a shift in reference status.
    Difference
    2%
    Check dated 2025-10-06T07:52:19.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Update: standardize disease name to 'Hemophilia B' and bump revision to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-29T04:10:55.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Updated trial eligibility from FIX:C = 2% to a broader range (up to 2%), added a future milestone date, and removed an earlier specific date and count.
    Difference
    0.3%
    Check dated 2025-09-22T00:31:51.000Z thumbnail image
  5. Check
    35 days ago
    Change Detected
    Summary
    Updated page revision from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.
    Difference
    0.1%
    Check dated 2025-09-14T21:39:21.000Z thumbnail image
  6. Check
    42 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content, names, pricing, or availability.
    Difference
    0.1%
    Check dated 2025-09-07T17:53:58.000Z thumbnail image
  7. Check
    49 days ago
    Change Detected
    Summary
    The webpage has been updated to include new facility names and locations, as well as recent publications related to Fidanacogene Elaparvovec gene therapy for Hemophilia B. Additionally, the last update date has been changed to August 2025, reflecting the latest information.
    Difference
    9%
    Check dated 2025-08-31T12:16:33.000Z thumbnail image

Stay in the know with updates to Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Factor IX Gene Therapy in Severe Hemophilia B Clinical Trial page.